메뉴 건너뛰기




Volumn 31, Issue 6, 2013, Pages 519-531

Cost effectiveness of targeted high-dose atorvastatin therapy following genotype testing in patients with acute coronary syndrome

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; KINESIN; KINESIN 6; UNCLASSIFIED DRUG;

EID: 84878833599     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-013-0054-5     Document Type: Article
Times cited : (9)

References (29)
  • 1
    • 79751531393 scopus 로고    scopus 로고
    • Heart disease and stroke statistics - 2011 update: A report from the American Heart Association
    • American Heart Association Statistics Committee and Stroke Statistics Subcommittee et al. 21160056 10.1161/CIR.0b013e3182009701
    • Roger VL, Go AS, Lloyd-Jones DM, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-209.
    • (2011) Circulation. , vol.123 , Issue.4
    • Roger, V.L.1    Go, A.S.2    Lloyd-Jones, D.M.3
  • 2
    • 0035804846 scopus 로고    scopus 로고
    • Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
    • Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators et al. 11277825 10.1001/jama.285.13.1711 1:CAS:528:DC%2BD3MXivFGnurc%3D
    • Schwartz GG, Olsson AG, Ezekowitz MD, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285(13):1711-8.
    • (2001) JAMA , vol.285 , Issue.13 , pp. 1711-1718
    • Schwartz, G.G.1    Olsson, A.G.2    Ezekowitz, M.D.3
  • 4
    • 70349675844 scopus 로고    scopus 로고
    • Acute coronary syndromes: Morbidity, mortality, and pharmacoeconomic burden
    • 19355807
    • Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care. 2009;15(2 Suppl):S36-41.
    • (2009) Am J Manag Care. , vol.15 , Issue.SUPPL. 2
    • Kolansky, D.M.1
  • 5
    • 11144355354 scopus 로고    scopus 로고
    • Intensive versus moderate lipid lowering with statins after acute coronary syndromes
    • 15007110 10.1056/NEJMoa040583 1:CAS:528:DC%2BD2cXjtVeqtr8%3D
    • Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-504.
    • (2004) N Engl J Med. , vol.350 , pp. 1495-1504
    • Cannon, C.P.1    Braunwald, E.2    McCabe, C.H.3
  • 6
    • 38349171836 scopus 로고    scopus 로고
    • Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: Results from the PROVE IT-TIMI 22 study
    • 18222355 10.1016/j.jacc.2007.10.017 1:CAS:528:DC%2BD1cXhtV2ntL8%3D
    • Iakoubova OA, Sabatine MS, Rowland CM, et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol. 2008;51:449-55.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 449-455
    • Iakoubova, O.A.1    Sabatine, M.S.2    Rowland, C.M.3
  • 7
    • 38349118892 scopus 로고    scopus 로고
    • Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary disease in 2 prospective trials: The CARE and WOSCOPS trials
    • 18222353 10.1016/j.jacc.2007.05.057 1:CAS:528:DC%2BD1cXhtV2nt7c%3D
    • Iakoubova OA, Tong CH, Rowland CM, et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol. 2008;51:435-43.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 435-443
    • Iakoubova, O.A.1    Tong, C.H.2    Rowland, C.M.3
  • 8
    • 4544243333 scopus 로고    scopus 로고
    • Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial
    • 15337732 10.1001/jama.292.11.1307
    • de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA. 2004;292(11):1307-16.
    • (2004) JAMA , vol.292 , Issue.11 , pp. 1307-1316
    • De Lemos, J.A.1    Blazing, M.A.2    Wiviott, S.D.3
  • 9
    • 77956947971 scopus 로고    scopus 로고
    • KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy
    • 20854963 10.1016/j.amjcard.2010.05.033 1:CAS:528:DC%2BC3cXhtFOntbjF
    • Li Y, Iakoubova OA, Shiffman D, et al. KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy. Am J Cardiol. 2010;106(7):994-8.
    • (2010) Am J Cardiol. , vol.106 , Issue.7 , pp. 994-998
    • Li, Y.1    Iakoubova, O.A.2    Shiffman, D.3
  • 10
    • 75249095390 scopus 로고    scopus 로고
    • Adherence and chemoprevention in major cardiovascular disease: A simulation study of the benefits of additional use of statins
    • 20056964 10.1136/jech.2009.091033 1:STN:280:DC%2BC3c%2Fht1KltA%3D%3D
    • Shroufi A, Powles JW. Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins. J Epidemiol Community Health. 2010;64(2):109-13.
    • (2010) J Epidemiol Community Health. , vol.64 , Issue.2 , pp. 109-113
    • Shroufi, A.1    Powles, J.W.2
  • 11
    • 67649195258 scopus 로고    scopus 로고
    • Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain and Germany, based on the Treating to New Targets study
    • 18800232 10.1007/s10198-008-0126-1
    • Taylor DCA, Pandya A, Thompson D, et al. Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain and Germany, based on the Treating to New Targets study. Eur J Health Econ. 2009;10:255-65.
    • (2009) Eur J Health Econ , vol.10 , pp. 255-265
    • Taylor, D.C.A.1    Pandya, A.2    Thompson, D.3
  • 12
    • 0034044352 scopus 로고    scopus 로고
    • The natural history of prevalent ischaemic heart disease in middle-aged men
    • 10843823 10.1053/euhj.1999.1866 1:STN:280:DC%2BD3czpsFWlsw%3D%3D
    • Lampe FC, Whincup PH, Wannamethee SG, et al. The natural history of prevalent ischaemic heart disease in middle-aged men. Eur Heart J. 2000;21(13):1052-62.
    • (2000) Eur Heart J. , vol.21 , Issue.13 , pp. 1052-1062
    • Lampe, F.C.1    Whincup, P.H.2    Wannamethee, S.G.3
  • 13
    • 80051499508 scopus 로고    scopus 로고
    • Celera
    • Data on file. Celera, 2011.
    • (2011) Data on File
  • 14
    • 84878819029 scopus 로고    scopus 로고
    • Eden Prairie (MN): Optum Accessed 2 Jun 2012
    • DrugReimbursement.com (online database). Eden Prairie (MN): Optum; 2012. http://www.drugreimbursement.com/drc/. Accessed 2 Jun 2012.
    • (2012) DrugReimbursement.com (Online Database)
  • 15
    • 80054102146 scopus 로고    scopus 로고
    • Montvale (NJ): Thomson PDR
    • Drug topics red book 2010. Montvale (NJ): Thomson PDR; 2010.
    • (2010) Drug Topics Red Book 2010
  • 16
    • 79960145526 scopus 로고    scopus 로고
    • Cost estimation of cardiovascular disease events in the US
    • 21585226 10.2165/11584620-000000000-00000
    • O'Sullivan AK, Rubin J, Nyambose J, et al. Cost estimation of cardiovascular disease events in the US. Pharmacoeconomics. 2011;29(8):693-704.
    • (2011) Pharmacoeconomics. , vol.29 , Issue.8 , pp. 693-704
    • O'Sullivan, A.K.1    Rubin, J.2    Nyambose, J.3
  • 17
    • 79955601866 scopus 로고    scopus 로고
    • United States life tables 2006
    • Arias E. United States life tables 2006. Natl Vital Stat Rep. 2010;58(21):1-40.
    • (2010) Natl Vital Stat Rep. , vol.58 , Issue.21 , pp. 1-40
    • Arias, E.1
  • 18
    • 22244440228 scopus 로고    scopus 로고
    • A national catalog of preference-based scores for chronic conditions in the United States
    • 15970790 10.1097/01.mlr.0000172050.67085.4f
    • Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43:736-49.
    • (2005) Med Care. , vol.43 , pp. 736-749
    • Sullivan, P.W.1    Lawrence, W.F.2    Ghushchyan, V.3
  • 19
    • 33644556119 scopus 로고    scopus 로고
    • Visualizing coronary calcium is associated with improvements in adherence to statin therapy
    • 16051253 10.1016/j.atherosclerosis.2005.06.018 1:CAS:528: DC%2BD28XitVKgt78%3D
    • Kalia NK, Miller LG, Nasir K, et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185(2):394-9.
    • (2006) Atherosclerosis. , vol.185 , Issue.2 , pp. 394-399
    • Kalia, N.K.1    Miller, L.G.2    Nasir, K.3
  • 20
    • 84872605674 scopus 로고    scopus 로고
    • Patient knowledge of pharmacogenetic information improves adherence to statin therapy: Results of the additional KIF6 risk offers better adherence to statins (AKROBATS) trial
    • 10.1016/S0735-1097(12)61849-X
    • Charland SL, Agatep BC, Epstein RS, et al. Patient knowledge of pharmacogenetic information improves adherence to statin therapy: results of the additional KIF6 risk offers better adherence to statins (AKROBATS) trial. J Am Coll Cardiol. 2012;59(13):E1848.
    • (2012) J Am Coll Cardiol , vol.59 , Issue.13 , pp. 1848
    • Charland, S.L.1    Agatep, B.C.2    Epstein, R.S.3
  • 21
    • 70450221024 scopus 로고    scopus 로고
    • Much cheaper, almost as good: Decrementally cost-effective medical innovation
    • 19884627 10.7326/0003-4819-151-9-200911030-00011
    • Nelson AL, Cohen JT, Greenberg D, et al. Much cheaper, almost as good: decrementally cost-effective medical innovation. Ann Intern Med. 2009;151:662-7.
    • (2009) Ann Intern Med. , vol.151 , pp. 662-667
    • Nelson, A.L.1    Cohen, J.T.2    Greenberg, D.3
  • 22
    • 14644403669 scopus 로고    scopus 로고
    • Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia
    • 15735194 10.2337/diacare.28.3.595 1:CAS:528:DC%2BD2MXivVaisrs%3D
    • Parris ES, Lawrence DB, Mohn LA, et al. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005;28(3):595-9.
    • (2005) Diabetes Care. , vol.28 , Issue.3 , pp. 595-599
    • Parris, E.S.1    Lawrence, D.B.2    Mohn, L.A.3
  • 23
    • 78751621806 scopus 로고    scopus 로고
    • Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. (J Am Coll Cardiol. 2010 Nov 2, 56(19), pp. 1552-63. Erratum in)
    • 10.1016/j.jacc.2010.12.011 1:CAS:528:DC%2BC3MXosFeks7s%3D
    • Assimes TL, Hólm H, Kathiresan S, et al. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. (J Am Coll Cardiol. 2010 Nov 2, 56(19), pp. 1552-63. Erratum in). J Am Coll Cardiol. 2011;57(4):520.
    • (2011) J Am Coll Cardiol. , vol.57 , Issue.4 , pp. 520
    • Assimes, T.L.1    Hólm, H.2    Kathiresan, S.3
  • 24
    • 84892434147 scopus 로고    scopus 로고
    • KIF6 carrier status in Asians predicts beneficial response to statins
    • Fung G, Aparicio AF, Wu A, Smith A, Wong I. KIF6 carrier status in Asians predicts beneficial response to statins. Circulation. 2012;125:AP327.
    • (2012) Circulation. , vol.125 , pp. 327
    • Fung, G.1    Aparicio, A.F.2    Wu, A.3    Smith, A.4    Wong, I.5
  • 25
    • 80052762422 scopus 로고    scopus 로고
    • Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention
    • 21493817 10.1161/CIRCGENETICS.110.959353 1:CAS:528:DC%2BC3MXps1Onsrk%3D
    • Ridker PM, MacFadyen JG, Glynn RJ, et al. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention. Circ Cardiovasc Genet. 2011;4(3):312-7.
    • (2011) Circ Cardiovasc Genet. , vol.4 , Issue.3 , pp. 312-317
    • Ridker, P.M.1    MacFadyen, J.G.2    Glynn, R.J.3
  • 26
    • 79955875125 scopus 로고    scopus 로고
    • No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the Heart Protection Study
    • 21458191 10.1016/j.jacc.2011.02.015 1:CAS:528:DC%2BC3MXnslKms7o%3D
    • Hopewell JC, Parish S, Clarke R, et al. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the Heart Protection Study. J Am Coll Cardiol. 2011;57(20):2000-7.
    • (2011) J Am Coll Cardiol. , vol.57 , Issue.20 , pp. 2000-2007
    • Hopewell, J.C.1    Parish, S.2    Clarke, R.3
  • 27
    • 35248901000 scopus 로고    scopus 로고
    • Long-term follow-up of the West of Scotland coronary prevention study
    • 17928595 10.1056/NEJMoa065994 1:CAS:528:DC%2BD2sXhtFKmur%2FK
    • Ford I, Murray H, Packard CJ, et al. Long-term follow-up of the West of Scotland coronary prevention study. N Engl J Med. 2007;357(15):1477-86.
    • (2007) N Engl J Med. , vol.357 , Issue.15 , pp. 1477-1486
    • Ford, I.1    Murray, H.2    Packard, C.J.3
  • 28
    • 83755186157 scopus 로고    scopus 로고
    • A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: Two meta-analyses and a meta-regression analysis
    • 22216121 10.1371/journal.pone.0028834 1:CAS:528:DC%2BC38XksFCmtw%3D%3D
    • Ference BA, Yoo W, Flack JM, Clarke M. A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: two meta-analyses and a meta-regression analysis. PLoS ONE. 2011;6(12):e28834.
    • (2011) PLoS ONE. , vol.6 , Issue.12 , pp. 28834
    • Ference, B.A.1    Yoo, W.2    Flack, J.M.3    Clarke, M.4
  • 29
    • 77955467684 scopus 로고    scopus 로고
    • KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: Results from the PROSPER study
    • 20215968 10.1097/HJR.0b013e328336a0dd
    • Iakoubova OA, Robertson M, Tong CH, et al. KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study. Eur J Cardiovasc Prev Rehabil. 2010;17(4):455-61.
    • (2010) Eur J Cardiovasc Prev Rehabil. , vol.17 , Issue.4 , pp. 455-461
    • Iakoubova, O.A.1    Robertson, M.2    Tong, C.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.